Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Yuan, Y. Wang, T. Xia, Y. Shi, Z. He, P.

Immunogenicity and safety of the domestic and imported live-attenuated varicella vaccine in healthy Chinese populations: a systematic review and meta-analysis

  • Western Pacific
  • China
  • Newborn
  • Children
  • Adolescents
  • Adults
  • Varicella
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Martins, A. M. Valero Juan, L. F. Santos, M. Martins, J. P.

Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Modeling
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Pacheco-Haro, M. D. de Arenas-Arroyo, S. N. Diaz-Goni, V. Velasco-Lucio, E. J. Castellares-Gonzalez, C. I. Reynolds-Cortez, V. Simeon-Prieto, A. Ignateva, E. Martinez-Vizcaino, V.

Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis

  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Ballivian, J. Parker, E. P. K. Berrueta, M. Ciapponi, A. Argento, F. Bardach, A. Brizuela, M. Castellana, N. Comande, D. Kampmann, B. Mazzoni, A. Sambade, J. M. Stegelmann, K. Xiong, X. Munoz, F. M. Stergachis, A. Buekens, P.

Immunogenicity of COVID-19 Vaccines During Pregnancy A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2025 ∙ Davis, P. Montroy, J. Warshawsky, B. Abrams, E. M. Coward, L. Killikelly, A.

Immunogenicity of pre-exposure rabies vaccination comparing number of doses and routes of administration: A systematic review and meta-analyses

  • All age groups
  • Rabies
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Azam, B. Marti, M. Goel, A. Aggarwal, R.

Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review

  • All age groups
  • Hepatitis E
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ul Haq, M. Z. Irfan, H. Shah, M. S. U. Sumbal, A. Mughal, S. Ashraf, S. Basaria, A. A. A. Abdullah, Chacho, M. A. Ayalew, B. D.

Immunogenicity, safety and tolerability of 15-valent pneumococcal conjugate vaccine (V114) compared to 13-valent pneumococcal conjugate vaccine (PCV-13) in healthy infants: A systematic review and meta-analysis

  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chen, J. Yang, C. Lin, W. Cheng, X. He, H. Li, X. Yu, J.

Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Influenza
  • RSV (Respiratory syncytial virus)
  • Pertussis
  • Tuberculosis
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Regmi, S. Pande, R. Wyatt, T. H. Niederhauser, V.

Impact of COVID-19 on Parental Barriers to Childhood Vaccination: A Systematic Review

  • Americas
  • United States of America
  • Newborn
  • Children
  • Adolescents
  • Parents/caregivers
  • COVID-19
  • Hepatitis B
  • Rotavirus
  • Diphtheria
  • Tetanus
  • Pertussis
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Poliomyelitis
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Varicella
  • Hepatitis A
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...